Introduction: Vaccination for common pathogens implicated in causing respiratory illness in patients with Multiple Myeloma (MM) is now recommended by most experts. However, there is limited data regarding the effectiveness of vaccination in these patients.
Methods: We conducted a prospective study on the efficacy of pneumococcal, influenza, and COVID-19 vaccination in patients with newly diagnosed MM treated at our center between January and June 2021.